|
|
Article: Endocardial Solutions Reports First Quarter Results, ISO 9002 Certification and CE Mark
- Article from:
- PR Newswire
- Article date:
- May 4, 1998
CopyrightCOPYRIGHT 1998 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MINNEAPOLIS/ST. PAUL, Minn., May 4 /PRNewswire/ -- Endocardial Solutions, Inc. (Nasdaq: ECSI), which is engaged in the development of diagnostic products for the electrophysiology market, today reported financial results for first quarter 1998 and receipt of ISO 9002 certification for its electrophysiology workstation and a CE mark for its Ensite(TM) Catheter.
For the first quarter ended March 31, 1998, Endocardial Solutions (ESI) reported a net loss of $6,217,383, or $.69 per share, compared with a net loss of $1,865,264, or $1.09 per share, for the same period in 1997. The 1998 loss includes expenses of $3,585,602 related to a license agreement with ...
Related newspaper, magazine, and journal articles:
|
|
Article: St. Jude Medical and Endocardial Solutions, Inc. ...
Business Wire;
September 23, 2004 ;
700+ words
... ... Medical Inc. (NYSE:STJ) and Endocardial Solutions, Inc. (Nasdaq:ECSI) jointly ... St. Jude Medical will acquire Endocardial Solutions, Inc. for $11.75 per share ... of approximately $273 million. Endocardial Solutions, Inc. (ESI), located in St ...
|
|